| Metric | Q3 2023 | Q2 2023 | Q3 2022 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $334M | $333M | $282M | 0.3% | 18.3% |
| Op. Income | $129M | $137M | $142M | -5.6% | -8.9% |
| Gross Margin | 71.9% | 74.7% | 89.4% | -2.7pp | -17.5pp |
| Net Margin | 29.5% | 31.7% | 38.5% | -2.1pp | -9.0pp |
| EPS (Diluted) | $0.49 | $0.52 | $0.53 | -5.8% | -7.5% |
| Free Cash Flow | $91M | $40M | $169M | 127.8% | -46.1% |
| Item | Amount |
|---|---|
| REVENUE | $334M |
| Cost of Revenue | $94M |
| GROSS PROFIT | $240M |
| R&D Expenses | $0 |
| Selling & Marketing | $2M |
| General & Administrative | $69M |
| SG&A Expenses | $71M |
| Other Expenses | $40M |
| Operating Expenses | $111M |
| Cost & Expenses | $204M |
| OPERATING INCOME | $129M |
| Interest Income | $294M |
| Interest Expense | $92M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $129M |
| Income Tax Expense | $31M |
| Net Income from Continuing Ops | $98M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $98M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $98M |
| D&A | $8M |
| EBIT | $129M |
| EBITDA | $137M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $334M |
| Cost of Revenue | $94M |
| GROSS PROFIT | $240M |
| R&D Expenses | $0 |
| Selling & Marketing | $2M |
| General & Administrative | $69M |
| SG&A Expenses | $71M |
| Other Expenses | $40M |
| Operating Expenses | $111M |
| Cost & Expenses | $204M |
| OPERATING INCOME | $129M |
| Interest Income | $294M |
| Interest Expense | $92M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $129M |
| Income Tax Expense | $31M |
| Net Income from Continuing Ops | $98M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $98M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $98M |
| D&A | $8M |
| EBIT | $129M |
| EBITDA | $137M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $98M |
| Depreciation & Amortization | $8M |
| Stock-Based Compensation | $2M |
| Deferred Income Tax | $2M |
| Other Non-Cash Items | -$7M |
| Change in Working Capital | -$5M |
| OPERATING CASH FLOW | $99M |
| Capital Expenditure | -$8M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$6M |
| Sales/Maturities of Investments | $99M |
| Other Investing Activities | -$86M |
| NET CASH FROM INVESTING | -$2M |
| Net Debt Issuance | $300M |
| Common Stock Repurchased | -$6M |
| Common Dividends Paid | -$36M |
| Other Financing Activities | -$478M |
| NET CASH FROM FINANCING | -$220M |
| FREE CASH FLOW | $91M |
| Net Change in Cash | -$123M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $488M |
| Short-Term Investments | $3.5B |
| Net Receivables | $111M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $4.1B |
| PP&E (Net) | $397M |
| Goodwill | $1.4B |
| Intangible Assets | $51M |
| Long-Term Investments | $15.3B |
| Tax Assets | $223M |
| Other Non-Current Assets | $541M |
| TOTAL NON-CURRENT ASSETS | $17.9B |
| TOTAL ASSETS | $22.0B |
| Account Payables | $175M |
| Short-Term Debt | $160M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $16.5B |
| TOTAL CURRENT LIABILITIES | $16.9B |
| Long-Term Debt | $1.4B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $0 |
| TOTAL NON-CURRENT LIABILITIES | $1.4B |
| TOTAL LIABILITIES | $18.3B |
| Common Stock | $2M |
| Additional Paid-In Capital | $2.4B |
| Retained Earnings | $1.6B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$351M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $3.7B |
| Minority Interest | $0 |
| TOTAL EQUITY | $3.7B |
| TOTAL LIABILITIES & EQUITY | $22.0B |
| Total Debt | $1.6B |
| Net Debt | $1.1B |
